kabutan

Genky DrugStares, 8% Increase in Ordinary Profit, Update Record High for Fourth Consecutive Term

Tue Jul 29, 2025 3:30 pm JST Earnings

9267 Genky DrugStores Co.,Ltd. 【J-GAAP】

Earnings Report

Genky DrugStares Co.,Ltd. <9267> [TSE Prime] announced its financial results after the market closed on July 29th (15:30). The consolidated ordinary profit for the fiscal year ended June 2025 increased by 6.8% from the previous period to 9.89 billion yen. For the fiscal year ending June 2026, the consolidated ordinary profit is expected to grow by 8.1% to 10.7 billion yen, marking the fourth consecutive term of record-high profits. This will be the thirteenth consecutive term of revenue and the fourth consecutive term of profit growth.

In the most recent three-month period, from April to June (4Q), the consolidated ordinary profit grew 10.6% from the same period last year, reaching 2.85 billion yen. The operating profit margin remained almost flat, changing from 5.2% in the same period last year to 5.3%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun, 2023 169,059 6,709 7,079 4,764 156.9 12.50 Jul 24, 2023 J-GAAP
Jun, 2024 184,860 9,015 9,268 6,324 208.2 12.75 Jul 29, 2024 J-GAAP
Jun, 2025 200,786 9,658 9,899 7,066 232.5 13 Jul 29, 2025 J-GAAP
YoY +8.6% +7.1% +6.8% +11.7% +11.7%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun, 2025 Guidance 202,000 10,000 10,220 7,000 230.3 13 Jul 29, 2024 J-GAAP
Jun, 2025 Results 200,786 9,658 9,899 7,066 232.5 13 Jul 29, 2025 J-GAAP
Revision Rate -0.6% -3.4% -3.1% +0.9% +1.0%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 98,758 4,596 4,722 3,268 107.6 6.50 Jan 27, 2025 J-GAAP
Jul - Dec, 2025 Guidance 109,210 5,270 5,360 3,700 121.4 6.50 Jul 29, 2025 J-GAAP
YoY +10.6% +14.7% +13.5% +13.2% +12.9%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun, 2024 184,860 9,015 9,268 6,324 208.2 12.75 Jul 29, 2024 J-GAAP
Jun, 2025 200,786 9,658 9,899 7,066 232.5 13 Jul 29, 2025 J-GAAP
Jun, 2026 Guidance 221,840 10,500 10,700 7,500 246.1 13 Jul 29, 2025 J-GAAP
YoY +10.5% +8.7% +8.1% +6.1% +5.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 48,273 2,521 2,580 1,868 61.5 5.2 Jul 29, 2024 J-GAAP
Jul - Sep, 2024 50,050 2,272 2,300 1,584 52.1 4.5 Oct 28, 2024 J-GAAP
Oct - Dec, 2024 48,708 2,324 2,422 1,684 55.4 4.8 Jan 27, 2025 J-GAAP
Jan - Mar, 2025 48,625 2,243 2,324 1,605 52.8 4.6 Apr 28, 2025 J-GAAP
Apr - Jun, 2025 53,403 2,819 2,853 2,193 72.2 5.3 Jul 29, 2025 J-GAAP
YoY +10.6% +11.8% +10.6% +17.4% +17.3%

Related Articles